... of a poster for the GP2 Phase 2b clinical trial final efficacy analysis at the San Antonio Breast Cancer Symposium (SABCS) in a virtual format.".
News
- Grenwich Shares Skyrocket 2300% After Firm Presents 5-Year Clinical Breast Cancer Trial Data ...
- News briefing: ADC gets a speedy FDA review for their DLBCL therapy; Qiagen teams with the ...
The transatlantic biotech ADC Therapeutics is getting a speedy review for its ... MD Anderson has been ratcheting up its biotech partnerships in recent ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- News briefing: Pfizer and Vivet get the OK to start gene therapy trial for rare liver disorder; Florida ...
Florida-based biotech Generex has inked “the biggest deal (it) could even imagine,” bagging $50 million from a consortium of Chinese institutions that ...
- Updated: FDA gives Cellectis all clear after patient death halted off-the-shelf CAR-T trial
The Paris-based biotech said they changed the study's protocol to ... trial unveiled Wednesday at the virtual San Antonio Breast Cancer Symposium.
- One of biotech's flashiest startups is finally getting some competition from a pioneer in a brand new ...
Operating as the only biotech in the space since, they've landed big-money partnerships with Bayer and Merck, more venture cash and a couple more ...